ANA-negative Antitopoisomerase I Antibody Is Not Generally Accepted
نویسندگان
چکیده
منابع مشابه
Is the generally accepted strategy of machine-translation research optimal?
This paper first presents a theoretical interpretation of the translation process. It then analyzes existing machine-translation research strategies and points out that some of the generally accepted principles of these strategies are not optimal. Finally, an alternative strategy is proposed, based on the author's theoretical position and research results. The possibility of achieving independe...
متن کاملANA-negative systemic lupus erythematosus.
After implantation oftwo metal plates a 24 year old woman developed fever of unknown origin and successively more symptoms of an ANA-negative systemic lupus erythematosus (SLE). These symptoms resolved after removal of the plates and recurrred during patch testing of the metal components, which showed a reaction to molybdenum. A lymphocyte transformation test indicated a delayedtype hypersensit...
متن کاملAnalysis of human antitopoisomerase-I idiotypes.
Antibodies to topoisomerase-I are present in approximately 26% of patients with scleroderma and are rarely found in patients with other diseases. In the current study, the expression of the antitopoisomerase-I (antitopo-I) idiotype from two scleroderma patients (E.M. and S.G.) and from a healthy individual (N.M.) were studied. Idiotype EM-SCL was restricted to the three classes of antitopo-I, w...
متن کاملANA-Negative Hydralazine-Induced Pericardial Effusion
This case describes a patient with pericardial effusion as a phenomenon of the drug-induced lupus erythematosus (DILE) syndrome due to hydralazine. The relevance of this case report lies in the fact that although hydralazine has been a known causative agent of DILE, its presentation may involve a negative anti-nuclear antibody (ANA) study. Pericardial effusion is a documented adverse effect as ...
متن کاملThree of 7 hemoglobin A1c point-of-care instruments do not meet generally accepted analytical performance criteria.
BACKGROUND In 2009, we investigated the conformance of 8 hemoglobin A(1c) (Hb A(1c)) point-of-care (POC) instruments. Since then, instruments have improved and new devices are available on the market. In this second study, we evaluated the performance of DCA Vantage, Afinion, InnovaStar, Quo-Lab, Quo-Test, Cobas B101, and B-analyst Hb A(1c) POC instruments. METHODS Clinical and Laboratory Sta...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Journal of Rheumatology
سال: 2019
ISSN: 0315-162X,1499-2752
DOI: 10.3899/jrheum.190524